Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a significant obstacle in transferring research datasets to actual clinical settings.

Genomics can help to identify people who are more likely to develop glaucoma potentially long before any symptoms of the disease appear. Instead ...